Medtelligence: Linking Science to Clinical Practice

Linking Science
to Clinical Practice

Innovative, high-quality medical education for clinicians in cardiology and other specialties.

Featured

Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
CME/CE
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
- Daniel Judge, MD
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
CME/CE
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
- Kevin Alexander, MD
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
CME/CE
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
- Ahmad Masri, MD, MS
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
MinuteCE®
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
0.50 program credits
- Raman Sankar, MD, PhD
- Scott Aaronson, MD
0.50 program credits

Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
CME/CE
Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
- Jürgen Floege, MD
The Critical Interplay: CKD, HF, and Hyperkalemia
The Critical Interplay: CKD, HF, and Hyperkalemia
MinuteCE®
The Critical Interplay: CKD, HF, and Hyperkalemia
1.00 program credit
- James Burton, DM, FRCP
- Javed Butler, MD
- Ellie Kelepouris, MD, FACP, FAHA
- Patrick Rossignol, MD, PhD
1.00 program credit
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF 
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF 
MinuteCE®
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF 
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Patrick Rossignol, MD, PhD
1.00 program credit
Future Directions in Managing Hyperkalemia in CKD and HF
Future Directions in Managing Hyperkalemia in CKD and HF
MinuteCE®
Future Directions in Managing Hyperkalemia in CKD and HF
1.00 program credit
- Javed Butler, MD, MPH, MBA
- James Burton, DM, FRCP
1.00 program credit
Potassium Binders in Practice: Clinical Trial Evidence
Potassium Binders in Practice: Clinical Trial Evidence
MinuteCE®
Potassium Binders in Practice: Clinical Trial Evidence
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Patrick Rossignol, MD, PhD
1.00 program credit
Potassium Binders: Safety Comes First!
Potassium Binders: Safety Comes First!
MinuteCE®
Potassium Binders: Safety Comes First!
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Javed Butler, MD, MPH, MBA
1.00 program credit
Emerging Therapies in Managing Adult and Pediatric Patients With FSGS: Latest Data
Emerging Therapies in Managing Adult and Pediatric Patients With FSGS: Latest Data
MinuteCE®
Emerging Therapies in Managing Adult and Pediatric Patients With FSGS: Latest Data
1.00 program credit
- Vladimir Tesar
- Meghan Sise, MD
1.00 program credit
Current FSGS Treatment Landscape: More Questions Than Answers
Current FSGS Treatment Landscape: More Questions Than Answers
MinuteCE®
Current FSGS Treatment Landscape: More Questions Than Answers
1.00 program credit
- Vladimir Tesar
- Meghan Sise, MD
1.00 program credit